<PAGE>

                                  Exhibit 99.1
                                  ------------

Monday,  March 5, 2001, 5:00 pm Eastern Time

                   B2BSTORES.COM, INC. ADJOURNS ITS SPECIAL
                             STOCKHOLDER'S MEETING

Miami, FL.--(BUSINESS WIRE) -- March 5, 2001 -- b2bstores.com, Inc.
(Nasdaq:BTBC), today announced that the special stockholder's meeting held on
        ----
March 5, 2001 was called to order, then immediately adjourned until March 14,
2001 at 10:00 a.m., EST at 4400 Biscayne Blvd., Miami, Florida. The special
meeting had been called for the purpose of considering and voting upon proposals
to (a) merge IVAX Diagnostics, Inc., a leading developer, manufacturer and
marketer of diagnostic products and a wholly-owned subsidiary of IVAX
Corporation (AMEX:IVX), with and into b2bstores.com and (b) amend the
                  ---
certificate of incorporation of b2bstores.com to (i) increase its authorized
common stock from 25.0 million shares to 50.0 million shares and (ii) change its
name to "IVAX Diagnostics, Inc."

The special meeting was ajourned following the announcement by b2bstores.com
that, on Friday, March 2, 2001, after the close of business, it received notice
that ZERO.NET, Inc., a stockholder of b2bstores.com, filed a lawsuit against
b2bstores.com and certain of its directors in the District Court of the Western
District of Texas. The lawsuit alleges that b2bstores violated certain aspects
of Section 14(a) of the Securities Exchange Act of 1934 and that certain
directors breached their fiduciary duties in connection with the proposed
merger. The directors and officers of b2bstore.com deny the allegations and
intend to vigorously defend such claims.

Randall K. Davis, a Director of b2bstores.com, stated, "Although we believe that
this lawsuit is without merit, we decided that it would be better not to
complete the merger until we had more opportunity to assess and respond to it.
While ZERO.NET, the plaintiff in the lawsuit, voted against the merger, the
majority of stockholders of b2bstores.com have submitted proxy votes in favor of
the merger. We continue to believe that a merger with IVAX Diagnostics is the
best way to build stockholder value by providing the opportunity for our
stockholders to participate in the future growth of the healthcare diagnostics
marketplace."

Except for the historical matters contained herein, statements in this press
release are forward-looking and are made pursuant to the safe harbor provisions
of the Securities Litigation Reform Act of 1995. Investors are cautioned that
forward-looking statements involve risks and uncertainties that may affect the
business and prospects of b2bstores.com (the "Company"), including the risks
that the stockholders of the Company may not approve the merger with IVAX
Diagnostics, Inc.; that the merger may not be completed; that the Company's
stockholder value will not be enhanced following the merger; and other risks and
uncertainties that may cause results to differ materially from those set forth
in the forward-looking statements. In addition to the risk factors set
<PAGE>

forth above, investors should consider the economic, competitive, governmental,
technological and other factors discussed in the Company's Quarterly Reports on
Form 10-QSB and other filings with the Securities and Exchange Commission.